Cartesian Therapeutics
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, engages in the provision of mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA CAR-T directed against the B cell maturation...
Cartesian Therapeutics Logo
About Cartesian Therapeutics
Cartesian Therapeutics, Inc. develops biopharmaceutical treatments. The Company produces RNA cell therapy to hunt down pathogenic plasma cells that secrete autoantibodies that treat autoimmune disease. Cartesian Therapeutics operates in the United States.
Address
7495 New Horizon Way,
Frederick, 21703
United States
Year founded
2010
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
